Deep transfer learning methodologies reveal hidden heterogeneity in β-cells driven by type 2 diabetes and obesity.

The global type 1 diabetes (T1D) burden continues to increase rapidly, driven by rising cases, aging populations, improved ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 1 diabetes and obesity using ...

Patients with NSCLC completed the PROMIS-57 PRO quality-of-life measure and wore a Fitbit to monitor patient-generated health data from ST initiation through day 60. Demographic and clinical data were ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has approved an expanded indication for the ...

This summer has brought a significant uptick in creatine’s visibility in the popular and social media — searches for “is creatine good” were up by 76% on TikTok alone over the past month — and it has ...

A BMJ guideline put patient risk into the equation for assessing the suitability of SGLT-2 inhibitors and GLP-1 receptor agonist drugs for type 2 diabetes. Their use in type 2 diabetes was only ...

Metformin is the first therapy for almost everyone with type 2 diabetes, but studies show that the drug creates a risk of vitamin B12 deficiency. Your clinician should test your B12 levels regularly ...

GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...